Metraipolis › archive › dc_43bc5039b7e9

How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA — Europe PMC PMID:40359159

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40359159
DOI
10.1093/ndt/gfaf069
License (as archived)
solo-consultazione
Archived
2026-11-10T05:47:24.033Z
SHA-256 of the archived text
9ac655a7003949691e50b33b1a4b25cd69862fff52ed2f821070d69f90f84cc3
Stable URL of this page
https://metraipolis.com/documento/dc_43bc5039b7e9

How to cite

How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA — Europe PMC PMID:40359159 — Europe PMC (en), https://europepmc.org/article/MED/40359159 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_43bc5039b7e9 (Metraipolis archive dc_43bc5039b7e9, sha256 9ac655a7003949691e50b33b1a4b25cd69862fff52ed2f821070d69f90f84cc3)
BibTeX
@misc{dc43bc5039b7e9,
  title = {How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA — Europe PMC PMID:40359159},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40359159},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_43bc5039b7e9; sha256 9ac655a7003949691e50b33b1a4b25cd69862fff52ed2f821070d69f90f84cc3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40359159. Agents can read the archived copy with the MCP tool read_document.